Company / Assets per Share
NEKTAR THERAPEUTICS Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$22.64
FY2025
5-year range
$1.59 / $22.64
FY2021-FY2025
Trend
+1326.1%
vs FY2024
Sector context
#52 of 210
Health Care
What the data says
Assets per Share changed +1326% YoY in FY2025, a notable deviation from the 9-year average annual change of +159%.
Based on SEC 10-K filings.
22.64 in FY2025 with a 5-year CAGR of +21.0%. Top quartile in the Health Care sector.
Improved from $2.11 to $22.64 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- +80.8%
- 5-Year CAGR
- +21.0%
- 10-Year CAGR
- -
Sector benchmark
Top 25% in Health CareTop 25% of 210This company $22.64 Sector average $296.79
▼
-92.4% below sector average
Key checks
Key Insights
- In FY2025, assets per share increased 1326.1% year-over-year.
- Ranks #52 out of 210 companies in the Health Care sector.
- Lowest assets per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -11.97 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $22.64 | +1326.1% |
| FY2024 | $1.59 | -24.8% |
| FY2023 | $2.11 | -44.9% |
| FY2022 | $3.83 | -38.2% |
| FY2021 | $6.20 | -28.8% |
| FY2020 | $8.72 | -23.5% |
| FY2019 | $11.39 | -15.5% |
| FY2018 | $13.48 | +305.8% |
| FY2017 | $3.32 | -21.0% |
| FY2016 | $4.20 | +10.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026